Table 1.
in 2000-2001 | in 2006-2007 | ||||||
---|---|---|---|---|---|---|---|
CG | BC | CRC | CG | BC | CRC | ||
Died | 2 | 14 | 25 | ||||
Invited (n): | 131 | 95 | 51 | 117 | 81 | 26 | |
Consented (n): | 120 | 95 | 51 | 85 | 62 | 17 | |
Complete Data (n): | 115 | 95 | 49 | ||||
Censored Data | 7 | 4 | 1 | ||||
Women (n): | 80 | 95 | 30 | ||||
Age (mean): | 54 | 57.1 | 62 | ||||
(SD) | (14.2) | (9.9) | (12.2) | ||||
Marital Status: | |||||||
Married (n/%) | 75/65.2 | 59/62.1 | 33/67.3 | ||||
Single (n/%) | 13/11.3 | 8/8.4 | 6/12.2 | ||||
Divorced (n/%) | 15/13.0 | 13/13.7 | 5/10.2 | ||||
Widowed (n/%) | 8/7.0 | 9/9.5 | 4/8.2 | ||||
No details available (n/%) | 4/3.4 | 6/6.3 | 1/2.0 | ||||
Most recent profession: | |||||||
Worker (n/%) | 6/5.2 | 12/12.6 | 12/24.4 | ||||
Employee/civil servant (n/%) | 72/62.6 | 45/47.4 | 22/44.9 | ||||
Self employed (n/%) | 19/16.5 | 8/8.4 | 5/10.2 | ||||
House wife/husband (n/%) | 12/10.4 | 23/24.2 | 10/20.4 | ||||
Still in education (n/%) | 3/2.6 | 0/0 | 0/0 | ||||
No details available (n/%) | 3/2.6 | 7/7.3 | 0/0 | ||||
Pension (n/%) | |||||||
Karnofsky-I. | %(SD) of survivors: | 96.7(7.2) | 88.2(12.5) | ||||
UICC stages (n/%): | |||||||
I | 28/29.5 | 6/12 | |||||
II | 37/38.9 | 9/18 | |||||
I/II | 3/3.2 | - | |||||
III | 4/4.2 | 15/29 | |||||
II/III | - | 2/4 | |||||
IV | 23/24.2 | 19/37 | |||||
Grading (SD): | 2.0(0.62) | 2.25(0.51) | |||||
Metastasis localisation (n/%): | |||||||
Bone | 5/5.2 | 1/1.9 | |||||
Liver | - | 8/15.7 | |||||
Peritoneal | - | 2/3.9 | |||||
Lung | 2/2.1 | - | |||||
Multiple | 9/9.4 | 7/13.7 | |||||
others | 5/5.2 | 1/1.9 | |||||
Duration of disease | (Mean/SD): | 4.7/5.6 | 1.7/2.3 | ||||
Menopausal status at diagnosis: | |||||||
Premenopausal (n/%) | 38/39.6 | ||||||
Postmenopausal (n/%) | 53/55.2 | ||||||
Treatment: | |||||||
Operation: n/% | 93/97.9 | 51/100 | |||||
Chemotherapy: n/% | 55/57.9 | 22/44 | |||||
Radiotherapy: n/% | 55/57.9 | 8/15.7 | |||||
antihormonal therapy.: n/% | 55/57.9 | - | |||||
mistletoe therapy: n/% | 79/83.2 | 38/71.7 |
Abbreviations: control group (CG), breast cancer (BC), colorectal cancer (CRC)